Welcome to JOGO, where we address the hidden root of chronic, life-disrupting conditions: muscle dysfunction. Whether it’s urological issues like urinary incontinence, gastrointestinal challenges like chronic constipation, or neurological conditions, like post stroke spasticity, Parkinson's tremor, migraine; muscle dysfunction often lies at the core of these concerns. It’s a condition that can affect anyone—those managing stress, navigating aging, recovering from surgery, or living with neurological disorders. But there's hope, and JOGO is here to provide it.
Our approach is born from pioneering research at New York University's RUSK Institute and backed by years of scientific discovery into facilitating neuroplasticity—the brain’s remarkable power to rewire and heal itself. We’ve developed an innovative, digital therapeutic system that retrains the body’s neural pathways, restoring muscle function and ultimately transforming lives through JOGO EMG Biofeedback device. The JOGO EMG Biofeedback therapy sessions are delivered by globally trained and certified therapists, subjectively and objectively assessing the patient, setting target goal for individual patient, monitoring progress and improving overall quality of life.
JOGO therapy is an advanced digital therapeutic platform that leverages biofeedback and neuroplasticity principles to treat a range of conditions, including pain and movement disorders. A number of patients have reported symptom improvement with the help of JOGO therapy.
JOGO Digital Therapeutics platform was built after many decades of research. JOGO combines the best of technology components and clinical science to deliver better outcomes to patients across the world. JOGO-Gx therapeutic platform is cleared by US FDA (https://www.fda.gov/). JOGO is a Johnson & Johnson JLABS company.
JOGO digital therapeutics uses wearable sensors and Artificial Intelligence(AI) - supported by clinically validated protocols - to provide evidence driven treatments for pain, neuromuscular, musculoskeletal and pelvic floor disorders. Digital Therapeutics is a newly classified treatment modality by the Food and Drug Administration (FDA) of the USA
JOGO digital therapeutics uses the foundational science of EMG-Biofeedback, which has been studied for more than forty years. Studies of EMG-Biofeedback have been published in prestigious medical journals such as Nature and JAMA. EMG-Biofeedback is an approved - and most importantly - highly recommended treatment modality for pain, neurological and pelvic floor disorders.
Typical JOGO treatment is once a week for ten weeks, provided either in clinic or via telemedicine for most conditions. Patients with stroke may need longer treatment duration depending on the severity of the disability.
JOGO Health Private Limited,
1/1,11th Cross st., Shastri Nagar, Adyar, Chennai, Tamil Nadu 600020.
